| 1 |
30455244 | Role of TEM-1 β-Lactamase in the Predominance of Ampicillin-Sulbactam-Nonsusceptible Escherichia coli in Japan. | 2019 Feb |
3 |
| 2 |
21135189 | Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction. | 2011 Feb |
2 |
| 3 |
12876904 | Urine inhibitory titers against resistant Escherichia coli isolates after oral amoxicillin-sulbactam. | 2003 |
1 |
| 4 |
9044033 | pH effects on the inhibition of extended-spectrum and classical TEM beta-lactamases by penicillanic acid sulphones. | 1997 Jan |
1 |
| 5 |
9527373 | [Characterization of the resistance to combinations of beta lactams and inhibitors of beta-lactamases in Escherichia coli. Effect of the type and amount of beta-lactamase production]. | 1997 Nov |
1 |
| 6 |
8257123 | Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. | 1993 Oct |
1 |
| 7 |
1329633 | Effects of CO2 and pH on inhibition of TEM-1 and other beta-lactamases by penicillanic acid sulfones. | 1992 Sep |
1 |
| 8 |
2692515 | TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli. | 1989 Nov |
1 |
| 9 |
3263690 | Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. | 1988 Jul-Aug |
1 |